0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PSMA Antibody Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-3E12684
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global PSMA Antibody Market Research Report 2022
BUY CHAPTERS

Global PSMA Antibody Market Research Report 2024

Code: QYRE-Auto-3E12684
Report
April 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

PSMA Antibody Market Size

The global PSMA Antibody market was valued at US$ 394.6 million in 2023 and is anticipated to reach US$ 894.4 million by 2030, witnessing a CAGR of 12.4% during the forecast period 2024-2030.

PSMA Antibody Market

PSMA Antibody Market

PSMA Antibody, also known as Prostate-Specific Membrane Antigen antibody, is a specific antibody used to detect and study PSMA protein (Prostate-Specific Membrane Antigen).
PSMA is a membrane surface antigen that is highly expressed mainly in prostate tissue and is therefore often used as a marker for prostate cancer. In addition to its expression in prostate tissue, PSMA is also expressed at low levels in other tissues and tumors. Due to its important role in the diagnosis, staging and treatment of prostate cancer, PSMA antibodies have important application value in cancer diagnosis and research. PSMA antibody can be used to study the expression distribution of PSMA, diagnose prostate cancer, explore anti-tumor treatment strategies, etc., and help to understand the function and clinical application potential of PSMA in tumor biology.
This report aims to provide a comprehensive presentation of the global market for PSMA Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PSMA Antibody.

Report Scope

The PSMA Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PSMA Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PSMA Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of PSMA Antibody Market Report

Report Metric Details
Report Name PSMA Antibody Market
Accounted market size in 2023 US$ 394.6 million
Forecasted market size in 2030 US$ 894.4 million
CAGR 12.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Monoclonal Antibody
  • Polyclonal Antibody
Segment by Application
  • Flow Cytometry
  • ELISA
  • Western Blot
  • Immunoprecipitation
  • Immunofluorescence
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sino Biological, Inc., ACROBiosystems, Bio-Techne, Abcam, Elabscience Biotechnology Inc., LifeSpan BioSciences, Inc, ProSci Incorporated, Boster Biological Technology, Abbexa, Assay Genie, Innovative Research, G&P Biosciences, Arigo Biolaboratories Corp.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of PSMA Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of PSMA Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is PSMA Antibody Market growing?

Ans: The PSMA Antibody Market witnessing a CAGR of 12.4% during the forecast period 2024-2030.

What is the PSMA Antibody Market size in 2030?

Ans: The PSMA Antibody Market size in 2030 will be US$ 894.4 million.

Who are the main players in the PSMA Antibody Market report?

Ans: The main players in the PSMA Antibody Market are Sino Biological, Inc., ACROBiosystems, Bio-Techne, Abcam, Elabscience Biotechnology Inc., LifeSpan BioSciences, Inc, ProSci Incorporated, Boster Biological Technology, Abbexa, Assay Genie, Innovative Research, G&P Biosciences, Arigo Biolaboratories Corp.

What are the Application segmentation covered in the PSMA Antibody Market report?

Ans: The Applications covered in the PSMA Antibody Market report are Flow Cytometry, ELISA, Western Blot, Immunoprecipitation, Immunofluorescence, Others

What are the Type segmentation covered in the PSMA Antibody Market report?

Ans: The Types covered in the PSMA Antibody Market report are Monoclonal Antibody, Polyclonal Antibody

1 PSMA Antibody Market Overview
1.1 Product Overview and Scope of PSMA Antibody
1.2 PSMA Antibody Segment by Type
1.2.1 Global PSMA Antibody Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 PSMA Antibody Segment by Application
1.3.1 Global PSMA Antibody Market Value by Application: (2024-2030)
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Others
1.4 Global PSMA Antibody Market Size Estimates and Forecasts
1.4.1 Global PSMA Antibody Revenue 2019-2030
1.4.2 Global PSMA Antibody Sales 2019-2030
1.4.3 Global PSMA Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 PSMA Antibody Market Competition by Manufacturers
2.1 Global PSMA Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global PSMA Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global PSMA Antibody Average Price by Manufacturers (2019-2024)
2.4 Global PSMA Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PSMA Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PSMA Antibody, Product Type & Application
2.7 PSMA Antibody Market Competitive Situation and Trends
2.7.1 PSMA Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PSMA Antibody Players Market Share by Revenue
2.7.3 Global PSMA Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PSMA Antibody Retrospective Market Scenario by Region
3.1 Global PSMA Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global PSMA Antibody Global PSMA Antibody Sales by Region: 2019-2030
3.2.1 Global PSMA Antibody Sales by Region: 2019-2024
3.2.2 Global PSMA Antibody Sales by Region: 2025-2030
3.3 Global PSMA Antibody Global PSMA Antibody Revenue by Region: 2019-2030
3.3.1 Global PSMA Antibody Revenue by Region: 2019-2024
3.3.2 Global PSMA Antibody Revenue by Region: 2025-2030
3.4 North America PSMA Antibody Market Facts & Figures by Country
3.4.1 North America PSMA Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America PSMA Antibody Sales by Country (2019-2030)
3.4.3 North America PSMA Antibody Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe PSMA Antibody Market Facts & Figures by Country
3.5.1 Europe PSMA Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe PSMA Antibody Sales by Country (2019-2030)
3.5.3 Europe PSMA Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PSMA Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific PSMA Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific PSMA Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific PSMA Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America PSMA Antibody Market Facts & Figures by Country
3.7.1 Latin America PSMA Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America PSMA Antibody Sales by Country (2019-2030)
3.7.3 Latin America PSMA Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PSMA Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa PSMA Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa PSMA Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa PSMA Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PSMA Antibody Sales by Type (2019-2030)
4.1.1 Global PSMA Antibody Sales by Type (2019-2024)
4.1.2 Global PSMA Antibody Sales by Type (2025-2030)
4.1.3 Global PSMA Antibody Sales Market Share by Type (2019-2030)
4.2 Global PSMA Antibody Revenue by Type (2019-2030)
4.2.1 Global PSMA Antibody Revenue by Type (2019-2024)
4.2.2 Global PSMA Antibody Revenue by Type (2025-2030)
4.2.3 Global PSMA Antibody Revenue Market Share by Type (2019-2030)
4.3 Global PSMA Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global PSMA Antibody Sales by Application (2019-2030)
5.1.1 Global PSMA Antibody Sales by Application (2019-2024)
5.1.2 Global PSMA Antibody Sales by Application (2025-2030)
5.1.3 Global PSMA Antibody Sales Market Share by Application (2019-2030)
5.2 Global PSMA Antibody Revenue by Application (2019-2030)
5.2.1 Global PSMA Antibody Revenue by Application (2019-2024)
5.2.2 Global PSMA Antibody Revenue by Application (2025-2030)
5.2.3 Global PSMA Antibody Revenue Market Share by Application (2019-2030)
5.3 Global PSMA Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sino Biological, Inc.
6.1.1 Sino Biological, Inc. Corporation Information
6.1.2 Sino Biological, Inc. Description and Business Overview
6.1.3 Sino Biological, Inc. PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sino Biological, Inc. PSMA Antibody Product Portfolio
6.1.5 Sino Biological, Inc. Recent Developments/Updates
6.2 ACROBiosystems
6.2.1 ACROBiosystems Corporation Information
6.2.2 ACROBiosystems Description and Business Overview
6.2.3 ACROBiosystems PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ACROBiosystems PSMA Antibody Product Portfolio
6.2.5 ACROBiosystems Recent Developments/Updates
6.3 Bio-Techne
6.3.1 Bio-Techne Corporation Information
6.3.2 Bio-Techne Description and Business Overview
6.3.3 Bio-Techne PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bio-Techne PSMA Antibody Product Portfolio
6.3.5 Bio-Techne Recent Developments/Updates
6.4 Abcam
6.4.1 Abcam Corporation Information
6.4.2 Abcam Description and Business Overview
6.4.3 Abcam PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abcam PSMA Antibody Product Portfolio
6.4.5 Abcam Recent Developments/Updates
6.5 Elabscience Biotechnology Inc.
6.5.1 Elabscience Biotechnology Inc. Corporation Information
6.5.2 Elabscience Biotechnology Inc. Description and Business Overview
6.5.3 Elabscience Biotechnology Inc. PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elabscience Biotechnology Inc. PSMA Antibody Product Portfolio
6.5.5 Elabscience Biotechnology Inc. Recent Developments/Updates
6.6 LifeSpan BioSciences, Inc
6.6.1 LifeSpan BioSciences, Inc Corporation Information
6.6.2 LifeSpan BioSciences, Inc Description and Business Overview
6.6.3 LifeSpan BioSciences, Inc PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LifeSpan BioSciences, Inc PSMA Antibody Product Portfolio
6.6.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.7 ProSci Incorporated
6.6.1 ProSci Incorporated Corporation Information
6.6.2 ProSci Incorporated Description and Business Overview
6.6.3 ProSci Incorporated PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ProSci Incorporated PSMA Antibody Product Portfolio
6.7.5 ProSci Incorporated Recent Developments/Updates
6.8 Boster Biological Technology
6.8.1 Boster Biological Technology Corporation Information
6.8.2 Boster Biological Technology Description and Business Overview
6.8.3 Boster Biological Technology PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Boster Biological Technology PSMA Antibody Product Portfolio
6.8.5 Boster Biological Technology Recent Developments/Updates
6.9 Abbexa
6.9.1 Abbexa Corporation Information
6.9.2 Abbexa Description and Business Overview
6.9.3 Abbexa PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Abbexa PSMA Antibody Product Portfolio
6.9.5 Abbexa Recent Developments/Updates
6.10 Assay Genie
6.10.1 Assay Genie Corporation Information
6.10.2 Assay Genie Description and Business Overview
6.10.3 Assay Genie PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Assay Genie PSMA Antibody Product Portfolio
6.10.5 Assay Genie Recent Developments/Updates
6.11 Innovative Research
6.11.1 Innovative Research Corporation Information
6.11.2 Innovative Research PSMA Antibody Description and Business Overview
6.11.3 Innovative Research PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Innovative Research PSMA Antibody Product Portfolio
6.11.5 Innovative Research Recent Developments/Updates
6.12 G&P Biosciences
6.12.1 G&P Biosciences Corporation Information
6.12.2 G&P Biosciences PSMA Antibody Description and Business Overview
6.12.3 G&P Biosciences PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.12.4 G&P Biosciences PSMA Antibody Product Portfolio
6.12.5 G&P Biosciences Recent Developments/Updates
6.13 Arigo Biolaboratories Corp.
6.13.1 Arigo Biolaboratories Corp. Corporation Information
6.13.2 Arigo Biolaboratories Corp. PSMA Antibody Description and Business Overview
6.13.3 Arigo Biolaboratories Corp. PSMA Antibody Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Arigo Biolaboratories Corp. PSMA Antibody Product Portfolio
6.13.5 Arigo Biolaboratories Corp. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PSMA Antibody Industry Chain Analysis
7.2 PSMA Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PSMA Antibody Production Mode & Process
7.4 PSMA Antibody Sales and Marketing
7.4.1 PSMA Antibody Sales Channels
7.4.2 PSMA Antibody Distributors
7.5 PSMA Antibody Customers
8 PSMA Antibody Market Dynamics
8.1 PSMA Antibody Industry Trends
8.2 PSMA Antibody Market Drivers
8.3 PSMA Antibody Market Challenges
8.4 PSMA Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global PSMA Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global PSMA Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global PSMA Antibody Market Competitive Situation by Manufacturers in 2023
    Table 4. Global PSMA Antibody Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global PSMA Antibody Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global PSMA Antibody Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global PSMA Antibody Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market PSMA Antibody Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of PSMA Antibody, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of PSMA Antibody, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of PSMA Antibody, Product Type & Application
    Table 12. Global Key Manufacturers of PSMA Antibody, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global PSMA Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PSMA Antibody as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global PSMA Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global PSMA Antibody Sales by Region (2019-2024) & (K Units)
    Table 18. Global PSMA Antibody Sales Market Share by Region (2019-2024)
    Table 19. Global PSMA Antibody Sales by Region (2025-2030) & (K Units)
    Table 20. Global PSMA Antibody Sales Market Share by Region (2025-2030)
    Table 21. Global PSMA Antibody Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global PSMA Antibody Revenue Market Share by Region (2019-2024)
    Table 23. Global PSMA Antibody Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global PSMA Antibody Revenue Market Share by Region (2025-2030)
    Table 25. North America PSMA Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America PSMA Antibody Sales by Country (2019-2024) & (K Units)
    Table 27. North America PSMA Antibody Sales by Country (2025-2030) & (K Units)
    Table 28. North America PSMA Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America PSMA Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe PSMA Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe PSMA Antibody Sales by Country (2019-2024) & (K Units)
    Table 32. Europe PSMA Antibody Sales by Country (2025-2030) & (K Units)
    Table 33. Europe PSMA Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe PSMA Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific PSMA Antibody Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific PSMA Antibody Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific PSMA Antibody Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific PSMA Antibody Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific PSMA Antibody Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America PSMA Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America PSMA Antibody Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America PSMA Antibody Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America PSMA Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America PSMA Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa PSMA Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa PSMA Antibody Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa PSMA Antibody Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa PSMA Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa PSMA Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global PSMA Antibody Sales (K Units) by Type (2019-2024)
    Table 51. Global PSMA Antibody Sales (K Units) by Type (2025-2030)
    Table 52. Global PSMA Antibody Sales Market Share by Type (2019-2024)
    Table 53. Global PSMA Antibody Sales Market Share by Type (2025-2030)
    Table 54. Global PSMA Antibody Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global PSMA Antibody Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global PSMA Antibody Revenue Market Share by Type (2019-2024)
    Table 57. Global PSMA Antibody Revenue Market Share by Type (2025-2030)
    Table 58. Global PSMA Antibody Price (US$/Unit) by Type (2019-2024)
    Table 59. Global PSMA Antibody Price (US$/Unit) by Type (2025-2030)
    Table 60. Global PSMA Antibody Sales (K Units) by Application (2019-2024)
    Table 61. Global PSMA Antibody Sales (K Units) by Application (2025-2030)
    Table 62. Global PSMA Antibody Sales Market Share by Application (2019-2024)
    Table 63. Global PSMA Antibody Sales Market Share by Application (2025-2030)
    Table 64. Global PSMA Antibody Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global PSMA Antibody Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global PSMA Antibody Revenue Market Share by Application (2019-2024)
    Table 67. Global PSMA Antibody Revenue Market Share by Application (2025-2030)
    Table 68. Global PSMA Antibody Price (US$/Unit) by Application (2019-2024)
    Table 69. Global PSMA Antibody Price (US$/Unit) by Application (2025-2030)
    Table 70. Sino Biological, Inc. Corporation Information
    Table 71. Sino Biological, Inc. Description and Business Overview
    Table 72. Sino Biological, Inc. PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Sino Biological, Inc. PSMA Antibody Product
    Table 74. Sino Biological, Inc. Recent Developments/Updates
    Table 75. ACROBiosystems Corporation Information
    Table 76. ACROBiosystems Description and Business Overview
    Table 77. ACROBiosystems PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. ACROBiosystems PSMA Antibody Product
    Table 79. ACROBiosystems Recent Developments/Updates
    Table 80. Bio-Techne Corporation Information
    Table 81. Bio-Techne Description and Business Overview
    Table 82. Bio-Techne PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Bio-Techne PSMA Antibody Product
    Table 84. Bio-Techne Recent Developments/Updates
    Table 85. Abcam Corporation Information
    Table 86. Abcam Description and Business Overview
    Table 87. Abcam PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Abcam PSMA Antibody Product
    Table 89. Abcam Recent Developments/Updates
    Table 90. Elabscience Biotechnology Inc. Corporation Information
    Table 91. Elabscience Biotechnology Inc. Description and Business Overview
    Table 92. Elabscience Biotechnology Inc. PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Elabscience Biotechnology Inc. PSMA Antibody Product
    Table 94. Elabscience Biotechnology Inc. Recent Developments/Updates
    Table 95. LifeSpan BioSciences, Inc Corporation Information
    Table 96. LifeSpan BioSciences, Inc Description and Business Overview
    Table 97. LifeSpan BioSciences, Inc PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. LifeSpan BioSciences, Inc PSMA Antibody Product
    Table 99. LifeSpan BioSciences, Inc Recent Developments/Updates
    Table 100. ProSci Incorporated Corporation Information
    Table 101. ProSci Incorporated Description and Business Overview
    Table 102. ProSci Incorporated PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. ProSci Incorporated PSMA Antibody Product
    Table 104. ProSci Incorporated Recent Developments/Updates
    Table 105. Boster Biological Technology Corporation Information
    Table 106. Boster Biological Technology Description and Business Overview
    Table 107. Boster Biological Technology PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Boster Biological Technology PSMA Antibody Product
    Table 109. Boster Biological Technology Recent Developments/Updates
    Table 110. Abbexa Corporation Information
    Table 111. Abbexa Description and Business Overview
    Table 112. Abbexa PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Abbexa PSMA Antibody Product
    Table 114. Abbexa Recent Developments/Updates
    Table 115. Assay Genie Corporation Information
    Table 116. Assay Genie Description and Business Overview
    Table 117. Assay Genie PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Assay Genie PSMA Antibody Product
    Table 119. Assay Genie Recent Developments/Updates
    Table 120. Innovative Research Corporation Information
    Table 121. Innovative Research Description and Business Overview
    Table 122. Innovative Research PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Innovative Research PSMA Antibody Product
    Table 124. Innovative Research Recent Developments/Updates
    Table 125. G&P Biosciences Corporation Information
    Table 126. G&P Biosciences Description and Business Overview
    Table 127. G&P Biosciences PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. G&P Biosciences PSMA Antibody Product
    Table 129. G&P Biosciences Recent Developments/Updates
    Table 130. Arigo Biolaboratories Corp. Corporation Information
    Table 131. Arigo Biolaboratories Corp. Description and Business Overview
    Table 132. Arigo Biolaboratories Corp. PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Arigo Biolaboratories Corp. PSMA Antibody Product
    Table 134. Arigo Biolaboratories Corp. Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. PSMA Antibody Distributors List
    Table 138. PSMA Antibody Customers List
    Table 139. PSMA Antibody Market Trends
    Table 140. PSMA Antibody Market Drivers
    Table 141. PSMA Antibody Market Challenges
    Table 142. PSMA Antibody Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of PSMA Antibody
    Figure 2. Global PSMA Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global PSMA Antibody Market Share by Type in 2023 & 2030
    Figure 4. Monoclonal Antibody Product Picture
    Figure 5. Polyclonal Antibody Product Picture
    Figure 6. Global PSMA Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global PSMA Antibody Market Share by Application in 2023 & 2030
    Figure 8. Flow Cytometry
    Figure 9. ELISA
    Figure 10. Western Blot
    Figure 11. Immunoprecipitation
    Figure 12. Immunofluorescence
    Figure 13. Others
    Figure 14. Global PSMA Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global PSMA Antibody Market Size (2019-2030) & (US$ Million)
    Figure 16. Global PSMA Antibody Sales (2019-2030) & (K Units)
    Figure 17. Global PSMA Antibody Average Price (US$/Unit) & (2019-2030)
    Figure 18. PSMA Antibody Report Years Considered
    Figure 19. PSMA Antibody Sales Share by Manufacturers in 2023
    Figure 20. Global PSMA Antibody Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest PSMA Antibody Players: Market Share by Revenue in 2023
    Figure 22. PSMA Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global PSMA Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America PSMA Antibody Sales Market Share by Country (2019-2030)
    Figure 25. North America PSMA Antibody Revenue Market Share by Country (2019-2030)
    Figure 26. United States PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe PSMA Antibody Sales Market Share by Country (2019-2030)
    Figure 29. Europe PSMA Antibody Revenue Market Share by Country (2019-2030)
    Figure 30. Germany PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific PSMA Antibody Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific PSMA Antibody Revenue Market Share by Region (2019-2030)
    Figure 37. China PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. China Taiwan PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America PSMA Antibody Sales Market Share by Country (2019-2030)
    Figure 45. Latin America PSMA Antibody Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa PSMA Antibody Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa PSMA Antibody Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE PSMA Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of PSMA Antibody by Type (2019-2030)
    Figure 55. Global Revenue Market Share of PSMA Antibody by Type (2019-2030)
    Figure 56. Global PSMA Antibody Price (US$/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of PSMA Antibody by Application (2019-2030)
    Figure 58. Global Revenue Market Share of PSMA Antibody by Application (2019-2030)
    Figure 59. Global PSMA Antibody Price (US$/Unit) by Application (2019-2030)
    Figure 60. PSMA Antibody Value Chain
    Figure 61. PSMA Antibody Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart